A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Κύριος συγγραφέας: | Islam, Nahidul |
---|---|
Άλλοι συγγραφείς: | Talukder, Mesbah |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
Brac University
2023
|
Θέματα: | |
Διαθέσιμο Online: | http://hdl.handle.net/10361/22025 |
Παρόμοια τεκμήρια
-
TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
ανά: Afroza, Halima
Έκδοση: (2024) -
Biologics and Biosimilars as Treatment Options for Psoriasis
ανά: Moya, Amena Khatun
Έκδοση: (2023) -
Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
ανά: Bishakha, Adwiza Chakraborty
Έκδοση: (2024) -
Safety and efficacy of dutasteride for male Androgenetic Alopecia
ανά: Islam, S.M. Zahidul
Έκδοση: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
ανά: Khandker, Tahia Anjum
Έκδοση: (2024)